Results 351 to 360 of about 8,234,457 (404)

Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness.

Journal of the American Medical Association (JAMA), 2018
Jacqueline Corrigan-Curay, Leonard Sacks, J. Woodcock   +2 more
semanticscholar   +1 more source

TEACHING DRUG SAFETY

American Journal of Psychiatry, 1965
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Drug Safety Evaluation in China

Current Allergy and Asthma Reports, 2019
Lisha Li, Jia Yin
semanticscholar   +1 more source

Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration

Drug Safety, 2022
David Croteau, Ellen Pinnow, E. Wu, M. Muñoz, I. Bulatao, G. D. Dal Pan   +5 more
semanticscholar   +1 more source

Drug Safety and Drug Control

The Journal of New Drugs, 1963
openaire   +2 more sources

Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China

Drug Safety, 2017
Yu Yang, Xiaofeng Zhou, Shuangqing Gao, Hong-bo Lin, Yanming Xie, Yuji Feng, Kui Huang, S. Zhan   +7 more
semanticscholar   +1 more source

Drug safety

The Lancet, 1993
P.A. Meredith, H.L. Elliott
openaire   +1 more source

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly